Prolactin is associated with bone mineral density in subjects with type 2 diabetes mellitus

被引:3
作者
Chen, Jia [1 ]
Liu, Geng [2 ]
Li, Quan [1 ]
Deng, Wei [1 ]
机构
[1] Beijing Jishuitan Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Beijing Jishuitan Hosp, Dept Emergency, Beijing, Peoples R China
关键词
type; 2; diabetes; prolactin; metabolism; bone mineral density; glucose; RISK; SCHIZOPHRENIA; OSTEOPOROSIS; EPIDEMIOLOGY; MECHANISMS; EXPRESSION; RECEPTOR;
D O I
10.3389/fendo.2022.964808
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
PurposeProlactin (PRL) exerts actions in the bone besides lactation and reproduction. This study aimed to investigate whether PRL is related to bone mineral density (BMD) in type 2 diabetes mellitus (T2DM). MethodsA total of 642 patients with T2DM were divided into two groups with age and body mass index (BMI) matched: mildly increased PRL (HP group, n = 101) or normal PRL (NP group, n = 541). BMD was measured by dual-energy X-ray absorptiometry and compared. Results1) BMD, T score at lumbar spine L1-4, right hip and femur neck, and Z score at the femur neck were significantly higher in the HP than in the NP group (0.96 +/- 0.16 vs. 0.92 +/- 0.15g/cm(2), p = 0.019; 0.88 +/- 0.15vs. 0.84 +/- 0.14 g/cm(2), p = 0.007; 0.75 +/- 0.17 vs.0.70 +/- 0.13 g/cm(2), p = 0.001; -0.90 (-1.85, -0.20) vs. -1.40 (-2.20, -0.40), p = 0.018; -0.80 (-1.50, -0.30) vs. -1.10 (-1.80, -0.53), p = 0.026; -1.30 (-2.00, -0.60) vs. -1.70 (-2.20, -1.00), p = 0.001; -0.20 (-0.70, 0.30) vs. -0.40 (-0.90, 0.10), p = 0.026). In men, T and Z scores at the right hip and femur neck were significantly higher in the HP than in the NP group (-0.70 (-1.32, 0.20) vs. -0.90 (-1.50, -0.40), p = 0.038; -0.20 (-0.80, 0.20) vs. -0.50 (-0.10, 0.10), p = 0.027; -0.30 (-0.60, -0.30) vs. -0.40 (-0.90, 0.20), p = 0.038) but not in women. Bone turnover markers have no significant difference between groups (all p > 0.05). 2) BMD at the right hip and Z score at the right hip and femur neck were significantly positively associated with PRL (r = 0.087, p = 0.029; r = 0.089, p = 0.024; r = 0.087, p = 0.029). In men, BMD at L1-4 and the right hip; T score at L1-4, the right hip, and the femur neck; and Z score at the right hip and the femur neck were significantly positively associated with PRL (r = 0.122, p = 0.007; r = 0.105, p = 0.041; r = 0.123, p = 0.016; r = 0.110, p = 0.032; r = 0.115, p = 0.025; r = 0.121, p = 0.018; r = 0.138, p = 0.007) but not significant in women. 3) In men divided into two groups according to T score (T score at the right hip>-1 or T score at the right hip <=-1) or the median BMD at L1-4, the right hip or the femur neck, PRL was significantly higher in the higher BMD than in the lower BMD group (16.32 +/- 6.12 vs. 14.78 +/- 5.68 ng/ml, p = 0.012; 16.20 +/- 6.21 vs. 14.73 +/- 5.40 ng/ml, p = 0.014; 16.10 +/- 6.01 vs. 14.80 +/- 5.77 ng/ml, p = 0.032; 16.17 +/- 6.04 vs. 14.76 +/- 5.77 ng/ml, p = 0.02; 16.48 +/- 6.05 vs. 14.98 +/- 5.81 ng/ml, p = 0.020; 16.10 +/- 5.98 vs. 14.80 +/- 5.87 ng/ml, p = 0.035). ConclusionIncreased PRL was associated with better BMD in patients with T2DM, especially in men. PRL within the biologically normal range may play a protective role in the BMD of T2DM.
引用
收藏
页数:10
相关论文
共 35 条
[1]
Al-Nami Marwa S, 2019, Int J Crit Illn Inj Sci, V9, P120, DOI [10.4103/ijciis.ijciis_40_19, 10.4103/IJCIIS.IJCIIS_40_19]
[3]
Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes? [J].
Balbach, Lisa ;
Wallaschofski, Henri ;
Voelzke, Henry ;
Nauck, Matthias ;
Doerr, Marcus ;
Haring, Robin .
BMC ENDOCRINE DISORDERS, 2013, 13
[4]
Expression of prolactin receptors in human osteosarcoma cells [J].
BatailleSimoneau, N ;
Gerland, K ;
Chappard, D ;
Basle, MF ;
Mercier, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (01) :323-328
[5]
High-calcium diet modulates effects of long-term prolactin exposure on the cortical bone calcium content in ovariectomized rats [J].
Charoenphandhu, Narattaphol ;
Tudpor, Kukiat ;
Thongchote, Kanogwun ;
Saengamnart, Wasana ;
Puntheeranurak, Supaporn ;
Krishnamra, Nateetip .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (02) :E443-E452
[6]
Osteoblasts are a new target for prolactin:: Analysis of bone formation in prolactin receptor knockout mice [J].
Clément-Lacroix, P ;
Ormandy, C ;
Lepescheux, L ;
Ammann, P ;
Damotte, D ;
Goffin, V ;
Bouchard, B ;
Amling, M ;
Gaillard-Kelly, M ;
Binart, N ;
Baron, R ;
Kelly, PA .
ENDOCRINOLOGY, 1999, 140 (01) :96-105
[7]
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization [J].
Colao, A ;
Di Somma, C ;
Loche, S ;
Di Sarno, A ;
Klain, M ;
Pivonello, R ;
Pietrosante, M ;
Salvatore, M ;
Lombardi, G .
CLINICAL ENDOCRINOLOGY, 2000, 52 (03) :319-327
[8]
Hyperprolactinemia and bone [J].
di Filippo, Luigi ;
Doga, Mauro ;
Resmini, Eugenia ;
Giustina, Andrea .
PITUITARY, 2020, 23 (03) :314-321
[9]
Bone Remodeling, Bone Mass and Weight Gain in Patients with Stabilized Schizophrenia in Real-Life Conditions Treated with Long-Acting Injectable Risperidone [J].
Doknic, Mirjana ;
Maric, Nadja P. ;
Britvic, Dubravka ;
Pekic, Sandra ;
Damjanovic, Aleksandar ;
Miljic, Dragana ;
Stojanovic, Marko ;
Radojicic, Zoran ;
Gasic, Miroslava Jasovic ;
Popovic, Vera .
NEUROENDOCRINOLOGY, 2011, 94 (03) :246-254
[10]
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects [J].
Halbreich, U ;
Kinon, BJ ;
Gilmore, JA ;
Kahn, LS .
PSYCHONEUROENDOCRINOLOGY, 2003, 28 :53-67